{
    "nctId": "NCT00263705",
    "briefTitle": "Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study",
    "officialTitle": "Adjuvant Capecitabine in Elderly Patients With Breast Cancer: a Phase II Study",
    "overallStatus": "COMPLETED",
    "conditions": "Elderly Patients, Breast Cancer",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE2",
    "allocation": "NON_RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 43,
    "primaryOutcomeMeasure": "safety of capecitabine in ederly",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Women aged \u00b370 years\n2. Histologic diagnosis of early breast cancer for which the treating physician considers adjuvant chemotherapy to be beneficial. Recommended situations are for example:\n\n   * endocrine non responsive (ER- and PgR -) and pT\\>1 cm, any T if N+ OR\n   * endocrine responsiveness doubtful (ER and/or PgR- or poor \\[3 to-5 according to Harvey score (12) or \u00a3 30% of positive cells by immunohistochemistry) and other risk factors (pT\u00b32 cm or N+ or G3 or Her-2/neu positive, etc.) OR\n   * endocrine responsive (ER and PgR \\> 5 according to Harvey score or \\> 30% of positive cells by immunohistochemistry) and at least two risk factors (pT\u00b3 2 cm, N+, G3, Her-2/neu positive, etc.) OR\n   * Very high risk (N\\>3) any ER/PgR.\n3. ECOG Performance status \u00a3 1\n4. No previous exposition to chemotherapy in the neoadjuvant setting\n5. Adequate organ function including:\n\n   1. neutrophils \u00b3 1.5 x 109 /l\n   2. platelets \u00b3100 x 109 / l\n   3. bilirubin \\< 1.25 x upper normal limit for the institution\n   4. transaminases \\< 2.5 x upper normal limit for the institution\n   5. calculated creatinine clearance of \\> 30ml/min (using the Crockoft and Gault formula)\n   6. absence of\n\n      * symptomatic ventricular arrhythmias;\n      * clinically significant Congestive Heart Failure;\n      * clinical and/or ECG evidence of myocardial infarction within the last 12 months;\n      * Coronary artery disease requiring medication.\n6. Absence of any psychological, familial or sociological condition or comorbidities that may affect compliance\n7. Written informed consent obtained according to local ethics committee guidelines -\n\nExclusion Criteria:\n\nN/A-",
    "sex": "FEMALE",
    "minimumAge": "70 Years",
    "stdAges": "OLDER_ADULT"
}